SNS Financial Group’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-20,000
| Closed | -$186K | – | 189 |
|
|
2023
Q4 | $186K | Hold |
20,000
| – | – | 0.02% | 180 |
|
|
2023
Q3 | $131K | Hold |
20,000
| – | – | 0.02% | 173 |
|
|
2023
Q2 | $163K | Hold |
20,000
| – | – | 0.02% | 177 |
|
|
2023
Q1 | $171K | Hold |
20,000
| – | – | 0.02% | 173 |
|
|
2022
Q4 | $185K | Hold |
20,000
| – | – | 0.03% | 183 |
|
|
2022
Q3 | $206K | Hold |
20,000
| – | – | 0.03% | 166 |
|
|
2022
Q2 | $200K | Hold |
20,000
| – | – | 0.03% | 175 |
|
|
2022
Q1 | $246K | Hold |
20,000
| – | – | 0.03% | 169 |
|
|
2021
Q4 | $347K | Hold |
20,000
| – | – | 0.04% | 154 |
|
|
2021
Q3 | $359K | Hold |
20,000
| – | – | 0.04% | 147 |
|
|
2021
Q2 | $457K | Hold |
20,000
| – | – | 0.06% | 127 |
|
|
2021
Q1 | $299K | Sell |
20,000
-50,000
| -71% | -$748K | 0.04% | 148 |
|
|
2020
Q4 | $378K | Hold |
70,000
| – | – | 0.05% | 126 |
|
|
2020
Q3 | $319K | Hold |
70,000
| – | – | 0.05% | 137 |
|
|
2020
Q2 | $344K | Hold |
70,000
| – | – | 0.06% | 120 |
|
|
2020
Q1 | $221K | Hold |
70,000
| – | – | 0.04% | 142 |
|
|
2019
Q4 | $181K | Hold |
70,000
| – | – | 0.03% | 186 |
|
|
2019
Q3 | $221K | Hold |
70,000
| – | – | 0.04% | 166 |
|
|
2019
Q2 | $236K | Hold |
70,000
| – | – | 0.04% | 167 |
|
|
2019
Q1 | $214K | Hold |
70,000
| – | – | 0.05% | 163 |
|
|
2018
Q4 | $109K | Hold |
70,000
| – | – | 0.03% | 172 |
|
|
2018
Q3 | $191K | Hold |
70,000
| – | – | 0.05% | 163 |
|
|
2018
Q2 | $183K | Hold |
70,000
| – | – | 0.05% | 163 |
|
|
2018
Q1 | $193K | Hold |
70,000
| – | – | 0.05% | 155 |
|
|
2017
Q4 | $225K | Hold |
70,000
| – | – | 0.05% | 153 |
|
|
2017
Q3 | $290K | Buy |
+70,000
| New | +$290K | 0.07% | 135 |
|